CLINICAL_TRIALS
ClinicalTrials.gov record update
Cemiplimab/PEG-Interferon-α Combination for Advanced Cutaneous Squamous Cell Carcinoma (aCSCC)
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT05729139
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:39:38.136526+00:00
- Published At
- 2023-08-09T00:00:00+00:00
- Record Updated At
- 2023-08-09
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Cutaneous Squamous Cell Carcinoma", "Squamous Cell Carcinoma", "Advanced Squamous Cell Carcinoma"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-08-09"- protocolSection.identificationModule.nctId
"NCT05729139"- protocolSection.identificationModule.officialTitle
"Cemiplimab/PEG-Interferon-\u03b1 Combination for Advanced Cutaneous Squamous Cell Carcinoma (aCSCC)"- protocolSection.statusModule.overallStatus
"WITHDRAWN"- protocolSection.designModule.phases
["PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.